Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-07-037610
Filing Date
2007-06-04
Accepted
2007-06-04 20:23:53
Documents
1
Period of Report
2007-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd161640.html 3  
1 FORM 3 rrd161640.xml 3 2112
  Complete submission text file 0001181431-07-037610.txt   3878
Mailing Address 1600 FARADAY AVE CARLSBAD CA 92008
Business Address 1600 FARADAY AVE CARLSBAD CA 92008 7606037200
INVITROGEN CORP (Issuer) CIK: 0001073431 (see all company filings)

EIN.: 330373077 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1600 FARADAY AVENUE CARLSBAD CA 92008
Business Address 650-343-1867
Grossman Paul David (Reporting) CIK: 0001401768 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-25317 | Film No.: 07899177